Jingyu Xiang
Jingyu Xiang
Verified email at
Cited by
Cited by
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ...
The Journal of clinical investigation 122 (10), 3579-3592, 2012
Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment
E Heller, MA Hurchla, J Xiang, X Su, S Chen, J Schneider, KS Joeng, ...
Cancer research 72 (4), 897-907, 2012
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells
H Celik, WK Koh, AC Kramer, EL Ostrander, C Mallaney, DAC Fisher, ...
Cancer cell 34 (5), 741-756. e8, 2018
Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
X Su, Y Xu, GC Fox, J Xiang, KA Kwakwa, JL Davis, JI Belle, WC Lee, ...
The Journal of clinical investigation 131 (20), 2021
Noncompetitive Modulation of the Proteasome by Imidazoline Scaffolds Overcomes Bortezomib Resistance and Delays MM Tumor Growth in Vivo
TA Lansdell, MA Hurchla, J Xiang, S Hovde, KN Weilbaecher, RW Henry, ...
ACS chemical biology 8 (3), 578-587, 2013
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
AK Esser, MH Ross, F Fontana, X Su, A Gabay, GC Fox, Y Xu, J Xiang, ...
Theranostics 10 (17), 7510, 2020
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
AK Esser, DA Rauch, J Xiang, JC Harding, NA Kohart, MH Ross, X Su, ...
Oncotarget 8 (41), 69250, 2017
Heparanase blockade as a novel dual-targeting therapy for COVID-19
J Xiang, M Lu, M Shi, X Cheng, KA Kwakwa, JL Davis, X Su, SJ Bakewell, ...
Journal of virology 96 (7), e00057-22, 2022
Targeted therapy to β3 integrin reduces chemoresistance in breast cancer bone metastases
GC Fox, X Su, JL Davis, Y Xu, KA Kwakwa, MH Ross, F Fontana, J Xiang, ...
Molecular cancer therapeutics 20 (6), 1183-1198, 2021
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
J Xiang, DA Rauch, DD Huey, AR Panfil, X Cheng, AK Esser, X Su, ...
JCI insight 4 (19), 2019
Evaluating acetate metabolism for imaging and targeting in multiple myeloma
F Fontana, X Ge, X Su, D Hathi, J Xiang, S Cenci, R Civitelli, KI Shoghi, ...
Clinical Cancer Research 23 (2), 416-429, 2017
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model
AK Esser, AH Schmieder, MH Ross, J Xiang, X Su, G Cui, H Zhang, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 201-211, 2016
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
J Xiang, M Shi, MA Fiala, F Gao, MP Rettig, GL Uy, MA Schroeder, ...
Blood Advances 6 (7), 1991-2000, 2022
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone
NA Kohart, SM Elshafae, W Supsahvad, A Alasonyalilar-Demirer, ...
Journal of Bone Oncology 19, 100257, 2019
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
J Xiang, JM Devenport, AJ Carter, KW Staser, MY Kim, J O’Neal, ...
Leukemia 37 (12), 2448-2456, 2023
Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors
NA Kohart, SM Elshafae, AA Demirer, WP Dirksen, JT Breitbach, ST Shu, ...
Leukemia & lymphoma 61 (2), 409-419, 2020
Despite Use of Upfront Plerixafor and G-CSF, Daratumumab Exposure Reduces Stem Cell Mobilization in Patients with Multiple Myeloma
J Edmisson, MA Fiala, MJ Slade, A Vickroy, M Kavanaugh, C Wilson, ...
Blood 140 (Supplement 1), 4295-4296, 2022
An “Off-the-shelf” CD2 universal CAR-T therapy combined with a long-acting IL-7 for T-cell Malignancies
J Xiang, J Devenport, AJ Carter, K Staser, MP Rettig, MY Kim, J O'Neal, ...
Blood 142, 764, 2023
The system can't perform the operation now. Try again later.
Articles 1–20